- Home
- PLRX vs THCH Comparison
PLRX vs THCH Comparison
Compare PLRX & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- THCH
- Stock Information
- Founded
- PLRX 2015
- THCH 2018
- Country
- PLRX United States
- THCH China
- Employees
- PLRX N/A
- THCH N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- THCH Blank Checks
- Sector
- PLRX Health Care
- THCH Finance
- Exchange
- PLRX Nasdaq
- THCH Nasdaq
- Market Cap
- PLRX 165.5M
- THCH 141.1M
- IPO Year
- PLRX 2020
- THCH N/A
- Fundamental
- Price
- PLRX $1.35
- THCH $2.98
- Analyst Decision
- PLRX Hold
- THCH
- Analyst Count
- PLRX 10
- THCH 0
- Target Price
- PLRX $9.79
- THCH N/A
- AVG Volume (30 Days)
- PLRX 2.5M
- THCH 16.3K
- Earning Date
- PLRX 03-03-2025
- THCH 04-17-2025
- Dividend Yield
- PLRX N/A
- THCH N/A
- EPS Growth
- PLRX N/A
- THCH N/A
- EPS
- PLRX N/A
- THCH N/A
- Revenue
- PLRX N/A
- THCH $207,029,179.00
- Revenue This Year
- PLRX N/A
- THCH N/A
- Revenue Next Year
- PLRX $46.66
- THCH N/A
- P/E Ratio
- PLRX N/A
- THCH N/A
- Revenue Growth
- PLRX N/A
- THCH N/A
- 52 Week Low
- PLRX $1.26
- THCH $2.78
- 52 Week High
- PLRX $16.52
- THCH $7.20
- Technical
- Relative Strength Index (RSI)
- PLRX 25.56
- THCH 44.38
- Support Level
- PLRX $1.42
- THCH $2.78
- Resistance Level
- PLRX $1.56
- THCH $3.05
- Average True Range (ATR)
- PLRX 0.12
- THCH 0.21
- MACD
- PLRX 0.24
- THCH -0.02
- Stochastic Oscillator
- PLRX 4.49
- THCH 27.78
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. It is also the operator and developer of Popeyes brand in Mainland China. The firm has two reportable segments; Tim Hortons which generates key revenue, and Popeyes. The company's revenue is derived from its operations in the PRC.